- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about REGN
Recent news which mentions REGN
New to Investing? Here's How You Can Get Started With $500.
September 10, 2023
From Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
September 09, 2023
From Motley Fool
2 Top Biotech Stocks to Buy in September
September 08, 2023
From Motley Fool
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,000 Today
September 05, 2023
Tickers
REGN
From Benzinga
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
September 05, 2023
From Motley Fool
10 growth stocks that are trading at bargain prices, including Delta and Cheniere Energy
August 30, 2023
From MarketWatch
Small Cancer Therapy Player Celularity To Provide Research Support For Regeneron's Therapy
August 29, 2023
From Benzinga
Wall Street Thinks This Tiny Biotech Company Could Soar Soon
August 28, 2023
From Motley Fool
These Are the ONLY 7 Penny Stocks to Consider in August 2023
August 26, 2023
From InvestorPlace
Could This Medicine Be the Next Winner for Novartis?
August 23, 2023
From Motley Fool
Top 5 Health Care Stocks That May Fall Off A Cliff
August 23, 2023
From Benzinga
Regeneron Awarded $326M Government Contract For COVID-19 Antibody Therapy Development
August 22, 2023
Tickers
REGN
From Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
August 22, 2023
Tickers
REGN
From Benzinga
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
August 21, 2023
From Benzinga
Value Stocks Outshine Growth Amidst Rising Treasury Yields: Key Sectors and Stocks Analyzed
August 21, 2023
From Benzinga
FDA Approves Regeneron's Drug For Ultra Rare Immune Disorder
August 21, 2023
Tickers
REGN
From Benzinga
FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
August 21, 2023
From Benzinga
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
August 21, 2023
From Motley Fool
18 Analysts Have This to Say About Regeneron Pharmaceuticals
August 16, 2023
Tickers
REGN
From Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
August 14, 2023
Tickers
REGN
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
August 11, 2023
From Benzinga
The 7 Best Value Stocks to Buy in August
August 10, 2023
From InvestorPlace
This Is What Whales Are Betting On Regeneron Pharmaceuticals
August 10, 2023
Tickers
REGN
From Benzinga
3 Top Biotech Stocks Defying the Bear Market
August 10, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.